| Noninvasive deep brain stimulation via temporally interfering electric fields N Grossman, D Bono, N Dedic, SB Kodandaramaiah, A Rudenko, HJ Suk, ... Cell 169 (6), 1029-1041. e16, 2017 | 685 | 2017 |
| Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1 D Refojo, M Schweizer, C Kuehne, S Ehrenberg, C Thoeringer, AM Vogl, ... Science 333 (6051), 1903-1907, 2011 | 346 | 2011 |
| Association of FKBP51 with priming of autophagy pathways and mediation of antidepressant treatment response: evidence in cells, mice, and humans NC Gassen, J Hartmann, J Zschocke, J Stepan, K Hafner, A Zellner, ... PLoS medicine 11 (11), e1001755, 2014 | 166 | 2014 |
| SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D2 Receptor Mechanism of Action N Dedic, PG Jones, SC Hopkins, R Lew, L Shao, JE Campbell, KL Spear, ... Journal of Pharmacology and Experimental Therapeutics 371 (1), 1-14, 2019 | 149 | 2019 |
| Cross-disorder risk gene CACNA1C differentially modulates susceptibility to psychiatric disorders during development and adulthood N Dedic, ML Pöhlmann, JS Richter, D Mehta, D Czamara, MW Metzger, ... Molecular psychiatry 23 (3), 533-543, 2018 | 147 | 2018 |
| The CRF family of neuropeptides and their receptors-mediators of the central stress response N Dedic, A Chen, JM Deussing Current molecular pharmacology 11 (1), 4-31, 2018 | 140 | 2018 |
| Pharmacological inhibition of the psychiatric risk factor FKBP51 has anxiolytic properties J Hartmann, KV Wagner, S Gaali, A Kirschner, C Kozany, G Rühter, ... Journal of Neuroscience 35 (24), 9007-9016, 2015 | 114 | 2015 |
| Chronic CRH depletion from GABAergic, long-range projection neurons in the extended amygdala reduces dopamine release and increases anxiety N Dedic, C Kühne, M Jakovcevski, J Hartmann, AJ Genewsky, KS Gomes, ... Nature neuroscience 21 (6), 803-807, 2018 | 112 | 2018 |
| Genetically dissecting P2rx7 expression within the central nervous system using conditional humanized mice MW Metzger, SM Walser, F Aprile-Garcia, N Dedic, A Chen, F Holsboer, ... Purinergic signalling 13 (2), 153-170, 2017 | 95 | 2017 |
| Neddylation inhibition impairs spine development, destabilizes synapses and deteriorates cognition AM Vogl, MM Brockmann, SA Giusti, G Maccarrone, CA Vercelli, ... Nature neuroscience 18 (2), 239-251, 2015 | 90 | 2015 |
| Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine M Kokkinou, EE Irvine, DR Bonsall, S Natesan, LA Wells, M Smith, ... Molecular psychiatry 26 (6), 2562-2576, 2021 | 74 | 2021 |
| Forebrain glutamatergic, but not GABAergic, neurons mediate anxiogenic effects of the glucocorticoid receptor J Hartmann, N Dedic, ML Pöhlmann, A Häusl, H Karst, C Engelhardt, ... Molecular psychiatry 22 (3), 466-475, 2017 | 68 | 2017 |
| Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies N Dedic, H Dworak, C Zeni, G Rutigliano, OD Howes International Journal of Molecular Sciences 22 (24), 13185, 2021 | 61 | 2021 |
| Heterozygosity for the mood disorder-associated variant Gln460Arg alters P2X7 receptor function and sleep quality MW Metzger, SM Walser, N Dedic, F Aprile-Garcia, V Jakubcakova, ... Journal of Neuroscience 37 (48), 11688-11700, 2017 | 54 | 2017 |
| Mineralocorticoid receptors dampen glucocorticoid receptor sensitivity to stress via regulation of FKBP5 J Hartmann, T Bajaj, C Klengel, C Chatzinakos, T Ebert, N Dedic, ... Cell Reports 35 (9), 109185, 2021 | 53 | 2021 |
| Fkbp52 heterozygosity alters behavioral, endocrine and neurogenetic parameters under basal and chronic stress conditions in mice J Hartmann, KV Wagner, N Dedic, D Marinescu, SH Scharf, XD Wang, ... Psychoneuroendocrinology 37 (12), 2009-2021, 2012 | 53 | 2012 |
| Assessing behavioural effects of chronic HPA axis activation using conditional CRH-overexpressing mice N Dedic, C Touma, CP Romanowski, M Schieven, C Kühne, M Ableitner, ... Cellular and molecular neurobiology 32 (5), 815-828, 2012 | 48 | 2012 |
| Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia MLR Heffernan, LW Herman, S Brown, PG Jones, L Shao, MC Hewitt, ... ACS Medicinal Chemistry Letters, 2021 | 43 | 2021 |
| Differential roles for L-type calcium channel subtypes in alcohol dependence S Uhrig, D Vandael, A Marcantoni, N Dedic, A Bilbao, MA Vogt, N Hirth, ... Neuropsychopharmacology 42 (5), 1058-1069, 2017 | 42 | 2017 |
| Deletion of CRH from GABAergic forebrain neurons promotes stress resilience and dampens stress-induced changes in neuronal activity N Dedic, C Kühne, KS Gomes, J Hartmann, KJ Ressler, MV Schmidt, ... Frontiers in Neuroscience 13, 986, 2019 | 41 | 2019 |
Jan DeussingPI, Max Planck Institute of PsychiatryVerified email at psych.mpg.de
